Rabbits immunized with Epstein-Barr virus gH/gL or gB recombinant proteins elicit higher serum virus neutralizing activity than gp350
-
Add time:08/28/2019 Source:sciencedirect.com
Epstein-Barr virus (EBV) is the primary cause of infectious mononucleosis and has been strongly implicated in the etiology of multiple epithelial and lymphoid cancers, such as nasopharyngeal carcinoma, gastric carcinoma, Hodgkin lymphoma, Burkitt lymphoma, non-Hodgkin lymphoma and post-transplant lymphoproliferative disorder. There is currently no licensed prophylactic vaccine for EBV. Most efforts to develop prophylactic vaccines have focused on EBV gp350, which binds to CD21/CD35 to gain entry into B cells, and is a major target of serum neutralizing antibody in EBV seropositive humans. However, a recombinant monomeric gp350 protein failed to prevent EBV infection in a phase II clinical trial. Thus, alternative or additional target antigens may be necessary for a successful prophylactic vaccine. EBV gH/gL and gB proteins coordinately mediate EBV fusion and entry into B cells and epithelial cells, strongly suggesting that vaccination with these proteins might elicit antibodies that will prevent EBV infection. We produced recombinant trimeric and monomeric EBV gH/gL heterodimeric proteins and a trimeric EBV gB protein, in addition to tetrameric and monomeric gp3501–470 proteins, in Chinese hamster ovary cells. We demonstrated that vaccination of rabbits with trimeric and monomeric gH/gL, trimeric gB, and tetrameric gp3501–470 induced serum EBV-neutralizing titers, using cultured human B cells, that were >100-fold, 20-fold, 18-fold, and 4-fold higher, respectively, than monomeric gp3501–470. These data strongly suggest a role for testing EBV gH/gL and EBV gB in a future prophylactic vaccine to prevent EBV infection of B cells, as well as epithelial cells.
We also recommend Trading Suppliers and Manufacturers of GB 52 (cas 123902-39-6). Pls Click Website Link as below: cas 123902-39-6 suppliers
Prev:Full length article640 Gb/s all-optical AND gate and wavelength converter using bulk SOA turbo–switched Mach–Zehnder interferometer with improved differential scheme
Next:Heat-induced retrieval of immunogold labeling for nucleobindin and osteoadherin from Lowicryl sections of bone) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Full length article640 Gb/s all-optical AND gate and wavelength converter using bulk SOA turbo–switched Mach–Zehnder interferometer with improved differential scheme08/27/2019
- EXPERIMENTAL STUDYEffect of acupuncture at Fengchi (GB 20) on the activity of myosin light chain kinase in the middle meningeal artery of migraine modeled rats08/26/2019
- Molecular characterization and virulence of an alphaherpesvirus isolated from a BoHV1 gB-seropositive and gE-seronegative Italian buffalo08/25/2019
- Competition, regulation and price controls in the GB retail energy market08/24/2019
- The enkephalinase inhibitor, GB 52 (cas 123902-39-6), does not affect nociceptive flexion reflexes nor pain sensation in humans08/23/2019
- The efficacy of HSV-2 vaccines based on gD and gB is enhanced by the addition of ICP2708/22/2019
- An initial assessment of the value of Allam Cycle power plants with liquid oxygen storage in future GB electricity system08/21/2019
- Gas and electricity supply implications of decarbonising heat sector in GB08/20/2019
- Decarbonising domestic heating: What is the peak GB demand?08/19/2019


